Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,932 | Dovepress* | 5,995+ | 1,375 | 7,370 | |
PubMed Central* | 937 | 382 | 1,319 | ||
Totals | 6,932 | 1,757 | 8,689 | ||
*Since 16 March 2016 +Since July 2016 |
View citations on PubMed Central and Google Scholar